Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 21, 2022 11:30 ET | Source: Transparency Market Research

Primary Progressive Multiple Sclerosis Treatment Market to Rise at 14.7% CAGR during Forecast Period, 2022 TMR Study

Wilmington, Delaware, United States, Dec. 21, 2022 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global primary progressive multiple sclerosis treatment industry was worth US$ 828.4 Mn...
January 03, 2019 10:01 ET | Source: Corbus Pharmaceuticals Holdings, Inc.

Corbus Pharmaceuticals Announces Strategic Collaboration with Kaken Pharmaceutical Co., Ltd. to Develop and Commercialize Lenabasum in Japan for Systemic Sclerosis and Dermatomyositis

Collaboration in-line with Corbus vision to become the global leader in the treatment of inflammatory and fibrotic diseases by targeting the endocannabinoid systemAdvances strategy to partner...